glp 1 agonist and dpp 4 inhibitor GLP-1 receptor agonists DPP-4 inhibitors Pathway, Pharmacodynamics Cardiovascular effects of DPP-4 inhibition:
Description
Gynecol Endocrinol
In vitro signaling studies demonstrated that tirzepatide was able to activate the GIP receptor with comparable potency to native GIP (57)
P =0.682)
353 i2231
